28th September 2023
21st September 2023
The Endpoints 11: The biotech startups making the biggest bets with the most exciting science in 2023
19th September 2023
ReCode Therapeutics Announces Closing of Extension to Series B Financing
2nd August 2023
Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
11th July 2023
Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer
24th May 2023
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
23rd May 2023
ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine
27th April 2023
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital
10th January 2023
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs
9th September 2022